MedPath

Clinical Performance of Two Reusable Silicone Hydrogel Contact Lenses

Not Applicable
Completed
Conditions
Refractive Errors
Registration Number
NCT05431478
Lead Sponsor
Alcon Research
Brief Summary

The purpose of this study is to assess the clinical performance of two reusable silicone hydrogel contact lenses when worn on a daily wear basis.

Detailed Description

In this crossover study, subjects will wear each study lens type for approximately 14 days and attend 7 scheduled visits. The expected duration of subject participation in the study is approximately 28 days (approximately 14 days per each study lens type).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
68
Inclusion Criteria
  • Successful wear of spherical soft contact lenses in both eyes for a minimum of 5 days per week and 8 hours per day during the past 3 months.
  • Best Corrected Visual Acuity of 20/25 Snellen (0.10 logMAR) or better in each eye.
  • Willing to stop wearing habitual contact lenses for the duration of study participation.
  • Other protocol-specified inclusion criteria may apply.

Key

Exclusion Criteria
  • Any eye infection, inflammation, abnormality or disease (including systemic) that contraindicates contact lens wear, as determined by the investigator.
  • Any use of systemic or ocular medications for which contact lens wear could be contraindicated, as determined by the investigator.
  • Habitual wear of AOHP contact lenses.
  • Habitual wear of any daily disposable contact lenses.
  • Other protocol-specified exclusion criteria may apply.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Visual Acuity With Study Lenses at Week 1 Follow-UpWeek 1, each wear period. A wear period was approximately 14 days.

Visual acuity (VA) was assessed with study lenses in place using logarithmic of the Minimum Angle of Resolution (logMAR) charts. A logMAR acuity of 0.0 corresponds to 20/20 Snellen acuity (normal visual acuity), with a negative value denoting better than 20/20 visual acuity. Each eye was assessed individually. No hypothesis testing was pre-specified for this endpoint.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (5)

Drs. Giedd, PA

🇺🇸

Maitland, Florida, United States

Wesley Optometric Consulting

🇺🇸

Medina, Minnesota, United States

ProCare Vision Center

🇺🇸

Granville, Ohio, United States

West Bay Eye Associates

🇺🇸

Warwick, Rhode Island, United States

Optometry Group, PLLC

🇺🇸

Memphis, Tennessee, United States

Drs. Giedd, PA
🇺🇸Maitland, Florida, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.